#antibodytestingforcovid19

[elainaledoyen]

The Various ELISA Assays that Can Help Determine a COVID-19 Diagnosis

The Covid-19 pandemic has snowballed into a massive global disaster, leading to more than three million confirmed cases of the illness in nations across the world. Here I have highlighted the importance of accurate and fast Covid-19 testing kits for pandemic management and about the role of ELISA assays in diagnosing patients with the novel coronavirus infection.

[elainaledoyen]

Antibody Testing for Covid-19: Revealing the Extent Of Covid-19 Spread

There are two types of tests being conducted in addressing the COVID-19 disease pandemic. The more commonly administered test is a qPCR assay designed to detect genomic material (RNA in this case) from the SARS-CoV-2 virus that causes the disease. The sample for this test is mucus and cells collected with a nasal swab inserted far back up a subject’s nose. A positive result indicates an active infection. Current recommendations from public health authorities are to quarantine the infected person for 14 days, after which period they are presumed to be incapable of spreading the virus to others. The other type of test that is important during the pandemic is a serology test to detect anti‑SARS‑CoV-2 antibodies in a subject’s blood. If present, these antibodies would have formed during an active infection sometime in the past from which the subject has recovered. The sample in this case is blood either from a finger prick or drawn from an arm vein. A positive on this test means that the person does not currently have the virus and is presumably no longer contagious, but had the disease and has now recovered. Because of the large percentage of asymptomatic cases of COVID-19, a positive test result can come as a bit of a shock, as the subject may not have been aware that they had been infected and therefore would not even know when they had been experiencing an active infection.